If a patient is led to believe they are receiving generic Ozempic when they are receiving a compounded salt formulation, this constitutes deceptive trade practice
Concentration0.5% w/v Dose500mg/100ml FeaturesAntibacterial IV Infusion Single dose Effective Convenient FormLiquid GradeMedicine PackagingSingle dose Price: 1230 INR/Piece MOQ1 Piece/Pieces Drug TypeInjection IngredientsErythropoeitin Injection Physical FormLiquid FunctionOther Recommended ForHuman being DosageAs per suggestion 3 Years CompositionMagnesium Chloride Concentration200mg/ml FeaturesMagnesium supplement Enzyme activator IV administration 50ml vial Rapid absorption MaterialGlass PackagingVial SterilitySterile MOQ100 Pack/Packs Drug TypeGeneral Medicines IngredientsPharmaceutical Injections Physical FormLiquid FunctionIncrease Immunity Recommended Forprescribed by physiciane DosageRecommended by the Doctor Price: 1560 INR/Piece MOQ100 Piece/Pieces Product TypeAvaxim Vaccine FeaturePain-Reducers Suitable ForAll Skin Type UseBody MOQ10 Pack/Packs Dosage FormInjection Drug TypeInjection Physical FormLiquid DosageAs Per Instructions Storage InstructionsDry And Cool Place 5 Years Price: 15 INR/Unit MOQ1 Unit/Units Purity99% Formulations TypeGeneral Drugs Formulations FormLiquid Storage InstructionsStore in Cool ApplicationHospital CertificationFDA Approved Drug typeInjection FeaturesEffective treatment Subcutaneous use Single dose vial FDA approved Prescription drug FormVial MaterialGlass Price Trend: 10000.00 - 100000.00 INR/Piece MOQ1 Piece/Pieces Origin of MedicineIndia ApplicationFor Hospital amd Clinic Purpose Product TypeSemi-Automated Pacakaging (Quantity Per Box)Available in 10ml 15ml & 20ml Packs Drug TypeOther Pharmaceutical Multihance Physical FormLiquid 10 Years Price: 2900.0 INR/Box MOQ1 Box/Boxes Brand Namecresp Dosage Forminjection Salt Compositiondarbepoeitin IngredientsCresp 60mcg Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy
Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, Suzuki K, Kasai K, Aso Y: Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice
The biological rationale is sound
Higher doses may intensify side effects such as nausea or restlessness, which can disrupt sleep in sensitive individuals
